Table 1.
Clinical and Biochemical Characteristics of Overweight/Obese and Control Subjects ()
| Overweight/obese (n = 282) | Controls (n = 172) | P | |
|---|---|---|---|
| Age (years) | 56.68 ± 9.73 | 54.32 ± 10.79 | (0.016) |
| Gender (M/F) | 169/113 | 95/77 | (0.303) |
| TG (mmol/l) | 2.36 ± 1.61 | 1.57 ± 1.43 | (0.000) |
| TC (mmol/l) | 5.70 ± 1.06 | 5.52 ± 1.24 | (0.087) |
| HDL‐C (mmol/l) | 1.19 ± 0.32 | 1.34 ± 0.43 | (0.000) |
| LDL‐C (mmol/l) | 3.52 ± 0.94a | 3.40 ± 1.05b | (0.395) |
| apo A‐I (mg/dl) | 127.51 ± 27.67 | 130.12 ± 24.25 | (0.294) |
| apo A‐II (mg/dl) | 28.99 ± 5.08 | 28.80 ± 6.54 | (0.663) |
| apo B100 (mg/dl) | 92.07 ± 18.41 | 85.47 ± 22.50 | (0.001) |
| apo C‐II (mg/dl) | 7.03 ± 3.33 | 5.71 ± 4.17 | (0.000) |
| apo C‐III (mg/dl) | 16.06 ± 6.75 | 13.28 ± 5.93 | (0.000) |
| apo E (mg/dl) | 5.36 ± 1.97 | 4.80 ± 2.12 | (0.014) |
| BMI (kg/m2) | 25.66 ± 2.22 | 20.89 ± 2.20 | (0.000) |
Subjects with TG > 4.516 mmol/l (400 mg/dl) were excluded when calculating the serum LDL‐C levels.
a
n = 262.
b
n = 163.